Skip to main content
logo
Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
36.22
-0.63 (-1.71%)
Aug 20, 2026, 10:07 AM EDT - Market open

Cogent Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6,2875,404862506808342
Market Cap Growth
271.40%527.16%70.14%-37.32%136.30%-2.42%
Enterprise Value
5,7395,181644273605228
Last Close Price
36.8535.527.805.8811.568.58

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
13.538.493.361.963.161.60
P/TBV Ratio
13.469.885.912.564.262.66

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.460.380.070.070.080.02
Net Debt / Equity Ratio
-1.03-1.04-1.05-0.99-0.94-1.01
Net Debt / EBITDA Ratio
1.422.000.991.241.632.87
Net Debt / FCF Ratio
1.772.491.291.631.913.58
Quick Ratio
13.3614.095.156.969.6612.86
Current Ratio
13.5714.245.327.099.8713.04
Return on Equity (ROE)
-109.74%-73.70%-99.54%-74.94%-59.69%-32.20%
Return on Assets (ROA)
-43.84%-32.93%-53.78%-42.35%-34.68%-19.55%
Return on Capital Employed (ROCE)
-50.20%-38.20%-101.40%-75.60%-54.00%-35.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.99%-6.09%-29.70%-38.00%-17.36%-21.14%
FCF Yield
-4.91%-4.92%-24.18%-30.89%-15.53%-17.69%
Buyback Yield / Dilution
-37.58%-24.09%-30.48%-35.41%-51.89%-249.52%
SEC Filings: 10-K · 10-Q